Table 1 Expression of miR-3622a-3p and SALL4 in human colorectal cancer and the patients’ clinicopathological characteristics.
Characteristics | Number | miR-3622a-3p expression | P-value | SALL4 expression | p-value | ||
|---|---|---|---|---|---|---|---|
High group | Low group | High group | Low group | ||||
Age(years) | Â | Â | Â | Â | Â | Â | Â |
≥60 | 32 | 17 | 15 | 0.82 | 18 | 14 | 0.494 |
<60 | 48 | 23 | 25 | Â | 22 | 26 | Â |
Gender | Â | Â | Â | Â | Â | Â | Â |
Male | 50 | 24 | 26 | 0.818 | 23 | 27 | 0.489 |
Female | 30 | 16 | 14 | Â | 17 | 13 | Â |
Size(cm) | Â | Â | Â | Â | Â | Â | Â |
≥3(cm) | 42 | 14 | 28 | 0.003** | 26 | 16 | 0.043* |
<3(cm) | 38 | 26 | 12 | Â | 14 | 24 | Â |
Stage | Â | Â | Â | Â | Â | Â | Â |
I/II | 45 | 26 | 19 | 0.176 | 21 | 24 | 0.652 |
III/IV | 35 | 14 | 21 | Â | 19 | 16 | Â |
T grade | Â | Â | Â | Â | Â | Â | Â |
T1 + T2 | 47 | 25 | 22 | 0.65 | 18 | 29 | 0.22 |
T3 + T4 | 33 | 15 | 18 |  | 22 | 11 |  |
Lymph node metastasis | Â | Â | Â | Â | Â | Â | Â |
N1–N3 | 48 | 18 | 30 | 0.012* | 29 | 19 | 0.039* |
N0 | 32 | 22 | 10 | Â | 11 | 21 | Â |
Histology grade | Â | Â | Â | Â | Â | Â | Â |
Well-moderately | 34 | 19 | 15 | 0.498 | 13 | 21 | 0.113 |
Poorly-signet | 46 | 21 | 25 | Â | 27 | 19 | Â |